Mouse (57 sources):
abnormal angiogenesis,
abnormal cardiac outflow tract development,
abnormal cell death,
abnormal cellular extravasation,
abnormal common myeloid progenitor cell morphology,
abnormal definitive hematopoiesis,
abnormal hematopoietic precursor cell number,
abnormal hematopoietic stem cell physiology,
abnormal intersomitic vessel morphology,
abnormal leukocyte migration,
abnormal lymphatic vessel endothelial cell morphology,
abnormal lymphatic vessel endothelium morphology,
abnormal placenta vasculature,
abnormal retina vasculature morphology,
abnormal somite development,
abnormal umbilical artery morphology,
abnormal umbilical cord blood vessel morphology,
abnormal uterus morphology,
abnormal vascular development,
abnormal vascular endothelial cell development,
abnormal vascular endothelial cell morphology,
abnormal vascular permeability,
abnormal vasculogenesis,
abnormal vein development,
abnormal visceral yolk sac blood island morphology,
abnormal vitelline vasculature morphology,
absent vitelline blood vessels,
cardiovascular system phenotype,
decreased angiogenesis,
decreased liver weight,
delayed heart development,
dilated dorsal aorta,
distended pericardium,
embryonic growth arrest,
embryonic growth retardation,
embryonic lethality during organogenesis, complete penetrance,
embryonic lethality during organogenesis, incomplete penetrance,
embryonic lethality, complete penetrance,
enlarged endometrial glands,
hematopoietic system phenotype,
immune system phenotype,
incomplete embryo turning,
incomplete somite formation,
increased apoptosis,
increased neutrophil cell number,
increased vascular permeability,
lethality throughout fetal growth and development, complete penetrance,
liver hypoplasia,
liver/biliary system phenotype,
no abnormal phenotype detected,
ovarian follicular cyst,
ovary fibrosis,
preweaning lethality, incomplete penetrance,
small liver,
small pharyngeal arch,
uterus fibrosis,
uterus hypertrophy
[+]
|